Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
19
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Mills C Randal | PRESIDENT AND CEO | 11 | $0 | $0 | 2023-06-21 |
| Jordan Maybelle | Director | 3 | $0 | $0 | 2023-06-08 |
| Colpman David | Director | 3 | $12.1K | $0 | 2023-06-08 |
| Zuga Matt | Director, 10% Owner | 3 | $0 | $0 | 2023-06-08 |
| Makes Brigid | Director | 4 | $7.3K | $0 | 2023-06-08 |
| Birchview Capital, LP | 10% Owner | 5 | $206.8K | $0 | 2023-03-27 |
| Englese Thomas | Chief Commercial Officer | 15 | $27.9K | $1.2K | 2023-03-09 |
| Ferguson Matthew | Chief Financial Officer | 16 | $151.9K | $0 | 2023-03-08 |
| HighCape Partners GP II, L.P. | 10% Owner | 1 | $0 | $0 | 2022-12-22 |
| Strobeck Matthew | 10% Owner | 6 | $398.2K | $0 | 2022-12-08 |
| HighCape Partners GP, L.P. | 10% Owner | 1 | $3.49M | $0 | 2022-12-05 |
| Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | 1 | $0 | $0 | 2022-10-20 |
| Riebman Jerome | Chief Medical Officer | 10 | $0 | $0 | 2022-09-08 |
| Edwards Peter G | GENERAL COUNSEL | 7 | $0 | $0 | 2022-09-08 |
| HighCape Co-Investment Vehicle I, LLC | 10% Owner | 8 | $7.50M | $0 | 2022-06-07 |
| Roberts Darryl | EVP, Operations & Product Deve | 7 | $0 | $0 | 2022-03-08 |
| LLOYD RONALD K. | President and CEO | 11 | $100.6K | $0 | 2022-03-08 |
| HIGHCAPE PARTNERS, L.P. | 10% Owner | 2 | $1.75M | $0 | 2021-12-08 |
| HighCape Capital, LLC | 10% Owner | 2 | $0 | $0 | 2021-06-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Mills C Randal | PRESIDENT AND CEO | M Exercise deriv | 2023-06-21 | 2023-06-23 | 22,474 | — | $0 | 67,419 | SEC↗ |
| Mills C Randal | PRESIDENT AND CEO | F Tax w/h | 2023-06-21 | 2023-06-23 | 7,772 | $2.41 | $18.7K | 62,710 | SEC↗ |
| Mills C Randal | PRESIDENT AND CEO | M Exercise | 2023-06-21 | 2023-06-23 | 22,474 | — | $0 | 70,482 | SEC↗ |
| Jordan Maybelle | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Colpman David | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Makes Brigid | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Zuga Matt | Director, 10% Owner | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Zuga Matt | Director, 10% Owner | A Award deriv | 2023-06-08 | 2023-06-12 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Mills C Randal | PRESIDENT AND CEO | A Award deriv | 2023-04-27 | 2023-04-28 | 134,840 | — | $0 | 134,840 | SEC↗ |
| Mills C Randal | PRESIDENT AND CEO | A Award deriv | 2023-04-27 | 2023-04-28 | 89,894 | — | $0 | 89,894 | SEC↗ |
| Mills C Randal | PRESIDENT AND CEO | M Exercise deriv | 2023-04-27 | 2023-04-28 | 44,947 | — | $0 | 89,893 | SEC↗ |
| Mills C Randal | PRESIDENT AND CEO | M Exercise | 2023-04-27 | 2023-04-28 | 44,947 | — | $0 | 48,008 | SEC↗ |
| Birchview Capital, LP | 10% Owner | P Buy | 2023-03-27 | 2023-03-27 | 10,000 | $1.59 | $15.9K | 1,655,184 | SEC↗ |
| Birchview Capital, LP | 10% Owner | P Buy | 2023-03-24 | 2023-03-27 | 2,000 | $1.35 | $2.7K | 1,645,184 | SEC↗ |
| Birchview Capital, LP | 10% Owner | P Buy | 2023-03-24 | 2023-03-27 | 18,000 | $1.35 | $24.3K | 1,643,184 | SEC↗ |
| Birchview Capital, LP | 10% Owner | P Buy | 2023-03-23 | 2023-03-27 | 100,000 | $1.49 | $149.0K | 1,615,184 | SEC↗ |
| Birchview Capital, LP | 10% Owner | P Buy | 2023-03-23 | 2023-03-27 | 10,000 | $1.49 | $14.9K | 1,625,184 | SEC↗ |
| Englese Thomas | CHIEF COMMERCIAL OFFICER | S Sale | 2023-03-09 | 2023-03-09 | 289 | $4.30 | $1.2K | 17,917 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2023-03-08 | 2023-03-09 | 1,287 | — | $0 | 2,575 | SEC↗ |
| Englese Thomas | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2023-03-08 | 2023-03-09 | 937 | — | $0 | 1,875 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | M Exercise | 2023-03-08 | 2023-03-09 | 1,287 | — | $0 | 46,504 | SEC↗ |
| Englese Thomas | CHIEF COMMERCIAL OFFICER | M Exercise | 2023-03-08 | 2023-03-09 | 937 | — | $0 | 18,206 | SEC↗ |
| Zuga Matt | Director, 10% Owner | A Award deriv | 2022-12-22 | 2022-12-27 | 17,533 | — | $0 | 17,533 | SEC↗ |
| HighCape Partners GP II, L.P. | 10% Owner | A Award deriv | 2022-12-22 | 2022-12-28 | 17,533 | — | $0 | 17,533 | SEC↗ |
| Colpman David | Director | P Buy | 2022-12-15 | 2022-12-16 | 3,098 | $3.90 | $12.1K | 3,098 | SEC↗ |
| Makes Brigid | Director | P Buy | 2022-12-09 | 2022-12-12 | 2,000 | $3.65 | $7.3K | 2,000 | SEC↗ |
| Strobeck Matthew | 10% Owner | P Buy | 2022-12-08 | 2023-02-13 | 9,061 | $3.79 | $34.3K | 1,511,184 | SEC↗ |
| Strobeck Matthew | 10% Owner | P Buy | 2022-12-08 | 2023-02-13 | 4,000 | $3.79 | $15.2K | 1,515,184 | SEC↗ |
| Strobeck Matthew | 10% Owner | P Buy | 2022-12-07 | 2023-02-13 | 10,000 | $3.58 | $35.8K | 1,468,123 | SEC↗ |
| Strobeck Matthew | 10% Owner | P Buy | 2022-12-07 | 2023-02-13 | 34,000 | $3.58 | $121.7K | 1,502,123 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | P Buy | 2022-12-05 | 2022-12-05 | 2,000 | $3.61 | $7.2K | 45,217 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | P Buy | 2022-12-05 | 2022-12-05 | 20,000 | $4.75 | $95.0K | 43,217 | SEC↗ |
| HighCape Partners GP, L.P. | 10% Owner | P Buy | 2022-12-05 | 2022-12-07 | 735,000 | $4.75 | $3.49M | 5,597,604 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | P Buy | 2022-12-02 | 2022-12-05 | 6,000 | $4.03 | $24.2K | 23,217 | SEC↗ |
| Strobeck Matthew | 10% Owner | P Buy | 2022-12-01 | 2023-02-13 | 40,000 | $4.75 | $190.0K | 1,458,123 | SEC↗ |
| Colpman David | Director | A Award deriv | 2022-10-20 | 2022-10-24 | 28,513 | — | $0 | 28,513 | SEC↗ |
| Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2022-10-20 | 2022-10-24 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Riebman Jerome | CHIEF MEDICAL OFFICER | M Exercise deriv | 2022-09-08 | 2022-09-12 | 14,758 | — | $0 | 0 | SEC↗ |
| CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2022-09-08 | 2022-09-12 | 15,390 | — | $0 | 0 | SEC↗ | |
| GENERAL COUNSEL | M Exercise deriv | 2022-09-08 | 2022-09-12 | 4,625 | — | $0 | 0 | SEC↗ | |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2022-09-08 | 2022-09-12 | 13,874 | — | $0 | 0 | SEC↗ |
| Riebman Jerome | CHIEF MEDICAL OFFICER | F Tax w/h | 2022-09-08 | 2022-09-12 | 5,104 | $7.30 | $37.3K | 14,989 | SEC↗ |
| Riebman Jerome | CHIEF MEDICAL OFFICER | M Exercise | 2022-09-08 | 2022-09-12 | 14,758 | — | $0 | 20,093 | SEC↗ |
| CHIEF COMMERCIAL OFFICER | M Exercise | 2022-09-08 | 2022-09-12 | 15,390 | — | $0 | 21,997 | SEC↗ | |
| CHIEF COMMERCIAL OFFICER | F Tax w/h | 2022-09-08 | 2022-09-12 | 4,728 | $7.30 | $34.5K | 17,269 | SEC↗ | |
| GENERAL COUNSEL | F Tax w/h | 2022-09-08 | 2022-09-12 | 1,127 | $7.30 | $8.2K | 3,498 | SEC↗ | |
| GENERAL COUNSEL | M Exercise | 2022-09-08 | 2022-09-12 | 4,625 | — | $0 | 4,625 | SEC↗ | |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | M Exercise | 2022-09-08 | 2022-09-12 | 13,874 | — | $0 | 22,015 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | F Tax w/h | 2022-09-08 | 2022-09-12 | 4,798 | $7.30 | $35.0K | 17,217 | SEC↗ |
| Mills C Randal | Interim President and CEO | A Award deriv | 2022-06-21 | 2022-06-23 | 182,511 | — | $0 | 182,511 | SEC↗ |
| Mills C Randal | Interim President and CEO | A Award deriv | 2022-06-21 | 2022-06-23 | 273,767 | — | $0 | 273,767 | SEC↗ |
| HighCape Co-Investment Vehicle | 10% Owner | A Award deriv | 2022-06-07 | 2022-06-09 | 22,090 | — | $0 | 22,090 | SEC↗ |
| HighCape Co-Investment Vehicle | 10% Owner | A Award deriv | 2022-06-07 | 2022-06-09 | 22,090 | — | $0 | 22,090 | SEC↗ |
| Jordan Maybelle | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 22,090 | — | $0 | 22,090 | SEC↗ |
| Makes Brigid | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 22,090 | — | $0 | 22,090 | SEC↗ |
| Mills C Randal | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 22,090 | — | $0 | 22,090 | SEC↗ |
| Strobeck Matthew | 10% Owner | P Buy | 2022-05-11 | 2023-02-13 | 200 | $5.96 | $1.2K | 1,418,123 | SEC↗ |
| Englese Thomas | CHIEF COMMERCIAL OFFICER | S Sale | 2022-03-10 | 2022-03-10 | 276 | — | $0 | 6,607 | SEC↗ |
| Edwards Peter G | GENERAL COUNSEL | A Award deriv | 2022-03-08 | 2022-03-10 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Edwards Peter G | GENERAL COUNSEL | A Award deriv | 2022-03-08 | 2022-03-10 | 8,700 | — | $0 | 8,700 | SEC↗ |
| Edwards Peter G | GENERAL COUNSEL | A Award deriv | 2022-03-08 | 2022-03-10 | 4,625 | — | $0 | 4,625 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-03-08 | 2022-03-10 | 8,700 | — | $0 | 8,700 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2022-03-08 | 2022-03-10 | 1,288 | — | $0 | 3,862 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-03-08 | 2022-03-10 | 13,874 | — | $0 | 13,874 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-03-08 | 2022-03-10 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Riebman Jerome | CHIEF MEDICAL OFFICER | A Award deriv | 2022-03-08 | 2022-03-10 | 8,700 | — | $0 | 8,700 | SEC↗ |
| Riebman Jerome | CHIEF MEDICAL OFFICER | A Award deriv | 2022-03-08 | 2022-03-10 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Riebman Jerome | CHIEF MEDICAL OFFICER | A Award deriv | 2022-03-08 | 2022-03-10 | 14,758 | — | $0 | 14,758 | SEC↗ |
| Riebman Jerome | CHIEF MEDICAL OFFICER | M Exercise deriv | 2022-03-08 | 2022-03-10 | 782 | — | $0 | 2,343 | SEC↗ |
| LLOYD RONALD K. | PRESIDENT AND CEO | A Award deriv | 2022-03-08 | 2022-03-10 | 39,894 | — | $0 | 39,894 | SEC↗ |
| LLOYD RONALD K. | PRESIDENT AND CEO | M Exercise deriv | 2022-03-08 | 2022-03-10 | 4,072 | — | $0 | 12,216 | SEC↗ |
| LLOYD RONALD K. | PRESIDENT AND CEO | A Award deriv | 2022-03-08 | 2022-03-10 | 37,788 | — | $0 | 37,788 | SEC↗ |
| LLOYD RONALD K. | PRESIDENT AND CEO | A Award deriv | 2022-03-08 | 2022-03-10 | 138,770 | — | $0 | 138,770 | SEC↗ |
| Roberts Darryl | EVP, OPERATIONS & PRODUCT DE | A Award deriv | 2022-03-08 | 2022-03-10 | 17,024 | — | $0 | 17,024 | SEC↗ |
| Roberts Darryl | EVP, OPERATIONS & PRODUCT DE | M Exercise deriv | 2022-03-08 | 2022-03-10 | 938 | — | $0 | 2,812 | SEC↗ |
| Roberts Darryl | EVP, OPERATIONS & PRODUCT DE | A Award deriv | 2022-03-08 | 2022-03-10 | 10,440 | — | $0 | 10,440 | SEC↗ |
| Roberts Darryl | EVP, OPERATIONS & PRODUCT DE | A Award deriv | 2022-03-08 | 2022-03-10 | 37,200 | — | $0 | 37,200 | SEC↗ |
| Englese Thomas | CHIEF COMMERCIAL OFFICER | A Award deriv | 2022-03-08 | 2022-03-10 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Englese Thomas | CHIEF COMMERCIAL OFFICER | A Award deriv | 2022-03-08 | 2022-03-10 | 8,700 | — | $0 | 8,700 | SEC↗ |
| Englese Thomas | CHIEF COMMERCIAL OFFICER | A Award deriv | 2022-03-08 | 2022-03-10 | 15,390 | — | $0 | 15,390 | SEC↗ |
| Englese Thomas | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2022-03-08 | 2022-03-10 | 938 | — | $0 | 2,812 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | M Exercise | 2022-03-08 | 2022-03-10 | 1,288 | — | $0 | 8,140 | SEC↗ |
| Riebman Jerome | CHIEF MEDICAL OFFICER | M Exercise | 2022-03-08 | 2022-03-10 | 782 | — | $0 | 5,334 | SEC↗ |
| LLOYD RONALD K. | PRESIDENT AND CEO | M Exercise | 2022-03-08 | 2022-03-10 | 4,072 | — | $0 | 31,775 | SEC↗ |
| Roberts Darryl | EVP, OPERATIONS & PRODUCT DE | M Exercise | 2022-03-08 | 2022-03-10 | 938 | — | $0 | 3,329 | SEC↗ |
| Englese Thomas | CHIEF COMMERCIAL OFFICER | M Exercise | 2022-03-08 | 2022-03-10 | 938 | — | $0 | 6,883 | SEC↗ |
| Englese Thomas | CHIEF COMMERCIAL OFFICER | P Buy | 2021-12-14 | 2021-12-15 | 4,580 | $6.10 | $27.9K | 5,088 | SEC↗ |
| HIGHCAPE PARTNERS, L.P. | 10% Owner | P Buy | 2021-12-08 | 2021-12-10 | 353,773 | $4.24 | $1.50M | 4,862,604 | SEC↗ |
| HIGHCAPE PARTNERS, L.P. | 10% Owner | P Buy | 2021-12-08 | 2021-12-10 | 58,962 | $4.24 | $250.0K | 90,807 | SEC↗ |
| Edwards Peter G | GENERAL COUNSEL | A Award deriv | 2021-08-31 | 2021-09-01 | 96,200 | — | $0 | 96,200 | SEC↗ |
| HighCape Capital, LLC | 10% Owner | A Award deriv | 2021-06-07 | 2021-06-09 | 14,082 | — | $0 | 14,082 | SEC↗ |
| HighCape Capital, LLC | 10% Owner | A Award deriv | 2021-06-07 | 2021-06-09 | 14,082 | — | $0 | 14,082 | SEC↗ |
| Mills C Randal | Director | A Award deriv | 2021-06-07 | 2021-06-09 | 14,082 | — | $0 | 14,082 | SEC↗ |
| Makes Brigid | Director | A Award deriv | 2021-06-07 | 2021-06-09 | 14,082 | — | $0 | 14,082 | SEC↗ |
| Jordan Maybelle | Director | A Award deriv | 2021-06-07 | 2021-06-09 | 14,082 | — | $0 | 14,082 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | P Buy | 2021-05-11 | 2021-05-12 | 1,000 | $11.00 | $11.0K | 2,300 | SEC↗ |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | P Buy | 2021-05-10 | 2021-05-12 | 1,300 | $11.14 | $14.5K | 1,300 | SEC↗ |
| LLOYD RONALD K. | PRESIDENT AND CEO | P Buy | 2021-05-07 | 2021-05-11 | 7,198 | $11.65 | $83.9K | 21,784 | SEC↗ |
| LLOYD RONALD K. | PRESIDENT AND CEO | P Buy | 2021-05-07 | 2021-05-11 | 1,367 | $12.28 | $16.8K | 23,151 | SEC↗ |
| LLOYD RONALD K. | President and CEO | C Conversion deriv | 2020-10-13 | 2020-10-13 | 111,788 | — | $0 | 0 | SEC↗ |
| HighCape Co-Investment Vehicle | 10% Owner | C Conversion deriv | 2020-10-13 | 2020-10-13 | 31,133,977 | — | $0 | 0 | SEC↗ |
| HighCape Co-Investment Vehicle | 10% Owner | X Exercise deriv | 2020-10-13 | 2020-10-13 | 7,655 | — | $0 | 0 | SEC↗ |
| LLOYD RONALD K. | President and CEO | C Conversion | 2020-10-13 | 2020-10-13 | 14,586 | — | $0 | 14,586 | SEC↗ |
| HighCape Co-Investment Vehicle | 10% Owner | C Conversion | 2020-10-13 | 2020-10-13 | 4,062,451 | — | $0 | 4,062,451 | SEC↗ |
| HighCape Co-Investment Vehicle | 10% Owner | F Tax w/h | 2020-10-13 | 2020-10-13 | 2,451 | $5.44 | $13.3K | 4,067,655 | SEC↗ |
| HighCape Co-Investment Vehicle | 10% Owner | P Buy | 2020-10-13 | 2020-10-13 | 441,176 | $17.00 | $7.50M | 4,508,831 | SEC↗ |
| HighCape Co-Investment Vehicle | 10% Owner | X Exercise | 2020-10-13 | 2020-10-13 | 7,655 | $5.44 | $41.6K | 4,070,106 | SEC↗ |
| Roberts Darryl | EVP, Operations & Product De | A Award deriv | 2020-10-07 | 2020-10-08 | 11,112 | — | $0 | 11,112 | SEC↗ |
| Roberts Darryl | EVP, Operations & Product De | A Award deriv | 2020-10-07 | 2020-10-08 | 50,083 | — | $0 | 50,083 | SEC↗ |
| Englese Thomas | Chief Commercial Officer | A Award deriv | 2020-10-07 | 2020-10-08 | 13,890 | — | $0 | 13,890 | SEC↗ |
| Englese Thomas | Chief Commercial Officer | A Award deriv | 2020-10-07 | 2020-10-08 | 33,488 | — | $0 | 33,488 | SEC↗ |
| Ferguson Matthew | Chief Financial Officer | A Award deriv | 2020-10-07 | 2020-10-08 | 81,800 | — | $0 | 81,800 | SEC↗ |
| LLOYD RONALD K. | President and CEO | A Award deriv | 2020-10-07 | 2020-10-08 | 100,425 | — | $0 | 100,425 | SEC↗ |
| LLOYD RONALD K. | President and CEO | A Award deriv | 2020-10-07 | 2020-10-08 | 181,783 | — | $0 | 181,783 | SEC↗ |
| Riebman Jerome | Chief Medical Officer | A Award deriv | 2020-10-07 | 2020-10-08 | 10,186 | — | $0 | 10,186 | SEC↗ |
| Riebman Jerome | Chief Medical Officer | A Award deriv | 2020-10-07 | 2020-10-08 | 30,412 | — | $0 | 30,412 | SEC↗ |